South African tycoon Stephen Saad's Aspen receives $220 million for menopause drug sale
Billionaires Africa | 06.11.2026 17:27
Aspen Pharmacare Holdings Ltd., the drugmaker led by South African tycoon Stephen Saad, has completed the sale of the European rights to its menopause treatment Ovestin after receiving the €197 million ($220 million) purchase price from the buyer.
